Contribution of Plasma Proteinase Inhibitors to the Regulation of Activated Protein C in Plasma

Summary

Activated protein C (APC), a serine protease, is regulated in plasma by protease inhibitors. This study was undertaken to determine the role of the major plasma inhibitors in regulating APC in plasma. Kinetic analysis and specific immunoassays for APC-inhibitor complexes were used to determine the inhibitors that form complexes with APC. Of the eight plasma inhibitors investigated, four interact with APC: protein C inhibitor (PCI), α₁-proteinase inhibitor (PI), α₂-antiplasmin (AP) and C1 esterase inhibitor (C1 Inh). The second order rate constants are: 1.3 × 10⁴ M⁻¹ s⁻¹ (PCI); 15 M⁻¹ s⁻¹ (PI); 410 M⁻¹ s⁻¹ (AP); and <6 M⁻¹ s⁻¹ (C1 Inh), with a relative effectiveness of each inhibitor to inactivate APC in plasma: 49:36:15:<1, respectively. PCI, PI and AP are the major inhibitors of APC in plasma. Low concentrations of APC will be inhibited by PCI with PI and AP playing a secondary role. However, as increasing APC is generated, PI and AP begin to play more important roles as the PCI is consumed.

• References

• 1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
• 2 van Hinsberg VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator inhibitor activity in endothelial cell conditioned media. Blood 1985; 65: 444-451
• 3 de Fouw MJ, Haverkate F, Bertina RM, Kopman J, van Wijngaarden A, van Hinsberg VWM. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 1986; 67: 1189-1193
• 4 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-168
• 5 Heeb MJ, Griffin JH. Physiologic inhibition of human activated protein C by α₁-antitrypsin. J Biol Chem 1988; 263: 11613-11617
• 6 van der Meer RJM, van Tilburg NH, van Wijngaarden A, van der Linden IK, Briët E, Bertina RM. A second plasma inhibitor of activated protein C: α₁-antitrypsin. Thromb Haemostas 1989; 62: 756-762
• 7 Heeb MJ, Espana F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood 1989; 73: 446-454
• 8 Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980; 66: 1186-1189
• 9 Suzuki K, Nishioka J, Kusumoto H. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-195
• 10 Suzuki K. Activated protein C inhibitor. Semin Thromb Hemostas 1984; 10: 154-161
• 11 Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 1987; 262: 15813-15816
• 12 Bao J, Sifers RN, Kidd JV, Ledley FD, Wo SLC. Molecular evolution of serpins: homologous structure of the human α₁-antichymotrypsin and α₁-antitrypsin genes. Biochemistry 1987; 26: 7755-7759
• 13 Suzuki K, Nishioka J, Hashimoto S, Kamiya T, Saito H. Normal titer of functional and immunoreactive protein C inhibitor in plasma of patients with congenital combined deficiency of factor V and factor VIII. Blood 1983; 62: 1266-1270
• 14 Meijers JCM, Kanters DHAJ, Vlooswijk RAA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-4235
• 15 Travis J, Johnson D. Human α₁-proteinase inhibitor. In: Proteolytic Enzymes. Lorand L. (ed). Meth Enzymol 1981. 80 754-765
• 16 Downing MR, Bloom JW, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 1978; 17: 2649-2653
• 17 Gitel SN, Medina VM, Wessler S. Inhibition of human activated factor X by antithrombin III and α₁-proteinase inhibitor in human plasma. J Biol Chem 1984; 259: 6890-6892
• 18 Marlar RA, Kressin DC. Activated protein C inhibition in plasma. Blood 1987; 70: 367a
• 19 Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63
• 20 Chase T, Shaw E. Titration of trypsin, plasmin, and thrombin with p-Nitrophenyl p’-Guanidinobenzoate HCl. Meth Enzymol 1970; 19: 20-27
• 21 Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S and the protein C inhibitor from a human hepatoma cell line. Blood 1986; 67: 64-70
• 22 Wiman B. Human α₂-antiplasmin. In: Proteolytic Enzymes. Lorand L. (ed). Meth Enzymol 1981. 80 395-408
• 23 Sim RB, Reboul A. Preparation and properties of human C1 inhibitor. In: Proteolytic Enzymes. Lorand C. (ed). Meth Enzymol. 1981. 80 43-54
• 24 Laurell M, Carlson TH, Stenflo J. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes. Thromb Haemostas 1988; 60: 334-339
• 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T₄ . Nature 1970; 227: 680-685
• 26 Weber K, Osborn M. The reliability of molecular weight determination by dodecylsulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
• 27 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some application. Proc Natl Acad Sci USA 1979; 76: 4350-4354
• 28 Harpel P. α₂-plasmin inhibitor and α₂-macroglobulin-plasmin complexes in plasma. J Clin Invest 1981; 68: 46-55
• 29 BioRad. DEAE affi-gel blue affinity media purifies IgG. Manufacturers Techn Bull. 1968 No 1062
• 30 Knight LC, Budzynski AZ, Olexa SA. Radiolabelling of fibrinogen using the iodogen technique. Thromb Haemostas 1981; 46: 593-596
• 31 Greffe BS, Manco-Johnson MJ, Marlar RA. Molecular forms of human protein C: Comparison and distribution in human plasma. Thromb Haemostas 1989; 62: 902-905
• 32 Heeb MJ, Gruber A, Griffin JH. Identification of divalent metal iondependent inhibition of activated protein C by α₂-macroglobulin and α₂-antiplasmin in blood and comparisons to inhibition of factors Xa, thrombin and plasmin. J Biol Chem 1991; 266: 17606-17612
• 33 Jane SM, Mitchell CA, Hau L, Salem HH. Inhibition of activated protein C by platelets. J Clin Invest 1989; 83: 222-226
• 34 Friedberg RC, Hagen PO, Pizzo SV. The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin. Blood 1988; 71: 1321-1328
• 35 Fuchs HE, Trapp HG, Griffith MJ, Roberts HR, Pizzo SV. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse: Role of the endothelium and the plasma proteinase inhibitors. J Clin Invest 1984; 73: 1696-1703
• 36 Rakoczi I, Wiman B, Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta 1978; 540: 295-350
• 37 Marcum JA, Rosenberg RD. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemostas 1987; 13: 464-474
• 38 Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-460
• 39 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2010
• 40 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
• 41 Walker FJ. Regulation of activated protein C by protein S. J Biol Chem 1981; 256: 11128-11132
• 42 Teitel JM, Rosenberg RD. Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 1983; 71: 1383-1391